On ECHEMI
Home > Drugs > Jilin Jinghui Pharmaceutical Co., Ltd.
Jilin Jinghui Pharmaceutical Co., Ltd.
  • Founded in:

    2000-11-02
  • Country:

    China China
  • Address:

    No. 88 Lianhua Road, Erdaojiang District, Tonghua City
  • Tax NO.:

    91220501724872381K
  • Registered Funds:

    50 million yuan
  • Website:

  • Email:

Related Drugs
Ketaling Capsules
Each capsule contains dry extract of Ficus microcarpa, chlorpheniramine maleate, etc.
Name Description Content CAS NO. Registered Holders
Dried leaf extract

0
Chlorphenamine maleate

113-92-8 28
Yanlixiao Capsules
Clove leaves.
Name Description Content CAS NO. Registered Holders
FOLIUM SYRINGAE

Antibacterial and improve immune function; has a strong inhibitory and killing effect on 22 pathogens such as Staphylococcus aureus, Pneumococcus, Pseudomonas aeruginosa, Shigella dysenteriae, etc.; can significantly increase the spleen-specific antibody-forming cells of mice and stimulate beta cell proliferation; can reduce myocardial contractility and blood pressure, thereby reducing myocardial oxygen consumption.

More

Antibacterial and improve immune function; has a strong inhibitory and killing effect on 22 pathogens such as Staphylococcus aureus, Pneumococcus, Pseudomonas aeruginosa, Shigella dysenteriae, etc.; can significantly increase the spleen-specific antibody-forming cells of mice and stimulate beta cell proliferation; can reduce myocardial contractility and blood pressure, thereby reducing myocardial oxygen consumption.

0
Xinkening Capsules
Salvia miltiorrhiza, Panax notoginseng, safflower, artificial bezoar, borneol, toad venom, buffalo horn concentrate powder, and ginseng root.
Name Description Content CAS NO. Registered Holders
Salvia Root P.E Tanshinone IIA 20%

0
NOTOGINSENG RADIX ET RHIZOMA

0
CARTHAMI FLOS

0
Atificial Cow-bezoar

1002-00-2 2
Borneol

507-70-0 1
Cinobufagin

470-37-1 0
water buffalo horn power

0
Ginseng root

0
Erythromycin Ethylsuccinate Tablets
The main ingredient of this product is erythromycin ethylsuccinate.
Name Description Content CAS NO. Registered Holders
Erythromycin ethylsuccinate

This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia, Chlamydia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

More

This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia, Chlamydia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

1264-62-6 25
Erythromycin Ethylsuccinate Tablets
The main ingredient of this product is erythromycin ethylsuccinate.
Name Description Content CAS NO. Registered Holders
Erythromycin ethylsuccinate

This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

More

This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

1264-62-6 25
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.